Next Article in Journal / Special Issue
Synthesis and Reactivity of Cyclic Oxonium Derivatives of nido-Carborane: A Review
Previous Article in Journal / Special Issue
Engineering the 2-Oxoglutarate Dehydrogenase Complex to Understand Catalysis and Alter Substrate Recognition
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Photocatalytic Degradation Pathways of the Valsartan Drug by TiO2 and g-C3N4 Catalysts

by
Feidias Bairamis
1 and
Ioannis Konstantinou
1,2,*
1
Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece
2
Institute of Environment and Sustainable Development, University Research Center of Ioannina (URCI), 45110 Ioannina, Greece
*
Author to whom correspondence should be addressed.
Reactions 2022, 3(1), 160-171; https://doi.org/10.3390/reactions3010012
Submission received: 10 December 2021 / Revised: 21 January 2022 / Accepted: 1 February 2022 / Published: 3 February 2022
(This article belongs to the Special Issue Feature Papers in Reactions in 2021)

Abstract

:
The photocatalytic degradation of the valsartan (VLS) pharmaceutical using TiO2 and g-C3N4 catalysts under simulated solar light is studied in this paper by high-resolution Orbitrap mass spectrometry. OH radicals were the major oxidant species for the degradation of valsartan using TiO2, while positive holes (h+), followed by a much lesser amount of OH radicals, were the major species in the case of g-C3N4. Valsartan degradation followed first order kinetics by both catalysts with TiO2 being the catalyst with the better photocatalytic efficiency. The transformation products (TPs) and their evolution profiles are identified and monitored, respectively, by means of LC-HRMS. Based on TPs identification, the degradation mechanisms are discussed. The major degradation pathways for g-C3N4 include decarboxylation and subsequent oxidation, hydroxylation, and cleavage of C–N bond, while for TiO2 cyclization, TPs are abundant and the hydroxylation occurs in the first stage products. The study highlights the complex nature of TPs formed during such processes, the different mechanisms involved and the necessity for the identification of TPs for the assessment of the treatment and the tracking of such TPs in different environmental compartments.

1. Introduction

During the last few years, the studies on the fate and transformation of pharmaceutical compounds are gaining scientific attention because of their continuous occurrence and increasing concentrations in different types of water, such as wastewater, surface water, ground water and even drinking water [1,2,3,4,5]. Valsartan (VAL) is an Angiotensin II receptor antagonist belonging to the commonest antihypertensive drugs [6,7]. As a result, high concentration levels of VAL in different types of water have been reported in several previous studies around the world. As example, the median and maximum concentration of VAL in surface waters from 33 European countries was 1507 and 7479 ng/L, respectively [8]. In addition, according to the studies of Castro et al. [9] and Peña Guzman et al. [10], maximum concentrations of VAL observed in wastewaters for Spain and 11 countries of Latin America were 9986 ng/L and 1900 ng/L, respectively. Finally, the presence of Valsartan in raw, secondary treated wastewaters and surface waters has been previously reported in our previous studies [11,12].
Because of this widespread occurrence of pharmaceutical residues, such as VLS, in different systems and the possible adverse effects that can exert in different organisms, advanced treatment technologies should be applied for environmental protection. Advanced oxidation processes (AOPs) have earned the attention because they can degrade/mineralize biorecalcitrant pollutants in short times. In addition, they can be applied to simulate oxidation processes in environmental media. Semiconductor photocatalysis is one of the most studied processes among AOPs with TiO2 being by far the most studied catalyst because of its chemical and photochemical stability, low cost and high photocatalytic performance. However, the photocatalytic activity of TiO2 using solar light is limited, because of its band gap (3.0–3.2 eV) [13,14]. g-C3N4, an alternative and promising polymeric semiconductor photocatalyst with visible light response (band gap 2.7 eV), has gained attention in recent years. This metal-free catalyst with a two-dimensional (2D) nanostructure demonstrates high thermal (up to 600 °C, in air) and chemical stability in acidic and basic media due to its s-triazinic structure, while it is insoluble in common solvents (ethanol, DMF, water) [15,16].
To date, very few studies performed lately deals with valsartan degradation in aqueous matrices by AOPs, i.e., by persulfate activation via sulfate radicals [17], photo-electro-Fenton [18], sonochemical degradation [19] and ozonation [20]. Some of these studies focused on the process parameters, while few data on the identification of degradation products are available. As a result, there is a lack of data concerning the heterogeneous semiconductor photocatalytic degradation of VLS in aquatic media.
Based on the above, the photocatalytic degradation of VAL by TiO2 (P25) and graphitic carbon nitride (g-C3N4) catalysts in aqueous suspensions is studied in the present study. The particular aims of the present work are: (a) the application of heterogeneous photocatalysis using TiO2 and g-C3N4 under simulated solar light for the removal of valsartan residues from water matrices, a topic that has not been investigated to date; (b) The identification of transformation products via the powerful instrumentation of ultra-performance liquid chromatography combined with high resolution and accurate mass linear ion trap-orbitrap mass spectrometer (UPLC—LIT–Orbitrap-MS); (c) the elucidation of transformation pathways by two different oxidant species, OH radicals and positive holes (h+).

2. Results and Discussion

2.1. Preliminary Experiments

Valsartan photocatalytic degradation kinetics using TiO2 and g-C3N4 catalysts are presented in Figure 1, while the linear transformation plot (natural logarithm of normalized concentration against irradiation time) is shown in the figure inset. Pseudo-first order kinetics were observed in both TiO2 and g-C3N4 cases (R2 > 0.979 and R2 > 0.9927) with 0.205 min−1 and 0.028 min−1 being the corresponding reaction rate constants. The degradation of valsartan in the dark followed very slow kinetics (k = 0.0003 min−1), while photolysis (k = 0.0059 min−1) under the same irradiation conditions was also a much slower process than photocatalysis.
The concentrations of OH radicals generated by TiO2 and g-C3N4 catalysts, as determined by the hydroxy-terephthalic acid fluorescence method (Figure 2), were 22.4 μΜ and 0.32 μΜ, respectively. The above results are consistent with the catalysts conduction band energy levels, showing that TiO2 photocatalytic degradation proceeded mainly through the generation of hydroxyl radicals, while g-C3N4 photocatalytic degradation proceed mainly through the positive holes and only a small amount of OH radicals was formed, probably through the oxygen reduction pathway with the sequential formation of superoxide radical anion, hydrogen peroxide and finally OH radicals. EVB and ECB of g-C3N4 were calculated at 1.58 eV and −1.24 eV, respectively while the OH-/OH and O2/O2•− potentials are 2.4 and −0.33 eV, respectively.

2.2. Photocatalytic Transformation Products and Pathways of Valsartan by UV-Vis/g-C3N4 Process

LC–HRMS identification data of VLS TPs by g-C3N4 photocatalysis are summarized in Table 1. Firstly, the parent compound (VLS) and sodium adduct [M + Na]+ were observed at m/z 436.2336 (C24H30O3N5+) and 458.2145 (C24H29O3N5Na+), respectively, while MS2 and MS3 fragments are closely identical to those reported elsewhere [18]. In addition, VLS showed also a pseudo-molecular ion [M-H] at m/z 434.2194 (C24H28O3N5) in the negative ionization mode due to the presence of the carboxylic acid functional group. The screening of TPs performed under negative ESI ionization can be used as an indicative tool for the presence of the carboxylic acid group in the structure of TPs.
Positive holes (h+) react principally with the electron-rich moieties of organic substances via electron transfer [21]. In the case of valsartan, such electron-rich functional group sites are the phenyl and tetrazole moieties as well as the carboxylic acid and tertiary amine groups. TP1, with [M + H]+/[M + Na]+ at m/z 392.22437/414.2253, respectively, differs 44 amu less than the parent drug and the matching chemical formula (C23H30ON5+) indicates clearly the loss of CO2 group. The formation of TP1 can be rationalized through a photo-Kolbe decarboxylation according to the following equation:
RCOO + h+ → R + CO2
TP2 with [M + H]+ at m/z 406.2227 and a chemical formula C23H30ON5+, having a difference of 14 amu from TP1, was assigned to a ketone derivative. In addition, TP5 with [M + H]+ at m/z 364.1759 and a chemical formula C20H22O2N5+ presented characteristic MS2/MS3 fragments that showed that the biphenyl-tetrazole and valeryl groups were intact. Similarly, TP6 with [M + H]+ at m/z 336.1810 and a chemical formula C19H22ON5+ was assigned to N-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl) pentanamide. The alkyl radical formed after decarboxylation can react rapidly with molecular oxygen, leading to the formation of peroxy radical. Peroxy radicals are disproportionate to alcohols and ketones via the Russell and/or Bennet–Summers mechanisms [22], but also form alkoxy radicals that lead to aldehyde, as well as fragmentation to form new alkyl radicals [23]. The formation of TP2, TP5 and TP6 can be rationalized by the above-mentioned mechanisms. Based on the TPs profile (Figure 3), the peak concentrations of the above products were observed in the same time framework; thus, it can be considered that took place concurrently.
Alternatively, the attack of holes to phenyl moieties via the electron transfer mechanism may lead to the generation of an unstable carbon-centered cationic radical that is subsequently hydrolyzed to produce the corresponding hydroxy derivative, OH-VLS. In the same way, the attack to the tetrazole moiety can lead also to the formation of a hydroxy analogue. TP3 and TP4 with [M − H] at m/z 450.2148 and 450.2144, respectively, and a chemical formula C24H28O4N5, differing 16 amu from VLS, were attributed to the hydroxy derivatives of VLS. Taking into account the MS2/MS3 characteristic fragments, the suggested hydroxylation position is on biphenyl or tetrazole ring. In a VAL sonochemical oxidation study, an OH-based process, Serna-Galvis and co-workers [19] identified four hydroxy-TPs of VLS at phenyl, tetrazole and valeryl functional groups. The similar hydroxylation pathway may be applied for the first stage generated products leading to the formation of secondary TPs, such as TP9 and TP7 as justified also by their evolution profiles (Figure 3). TP7 presented [M + H]+ at m/z 356.1341 and C17H18O4N5+ chemical formula, while TP9 presented [M + H]+ at m/z 400.1238 and C18H18O6N5+ as a chemical formula.
One-electron oxidation of tertiary amine group yielding a nitrogen centered cation radical [24] can represent another degradation pathway. This intermediate cation radical is subsequently subjected to C–N cleavage to generate transformation products TP10 and TP8 with concurrent hydroxylation. TP10 presented [M + H]+ m/z 202.1433 (C10H20O3N+), [M + Na]+ m/z 224.1249 (C10H19O3NNa+), while TP8 presented [M + H]+ m/z 267.0868, C14H11O2N4+. TP10 has been also previously detected along photo-electro-Fenton degradation of VLS (Martínez-Pachón et al. 2018). No significant removal of TOC was observed in the presence of g-C3N4, which, in addition to the slower degradation rates of TPs, could be probably due to the partial dissolution or presence of g-C3N4 nanoparticles.
Based on the mass spectra maximum intensities, the formation of TPs followed the sequence TP5 > TP6 > TP9 > TP3 > TP2 > TP1 > TP10 ≥ TP7,TP8,TP4, while the time interval for the formation of maximum concentration followed the trend TP5, TP6, TP1, TP2 (15–30 min) < TP4,TP3 (60 min) < TP7, TP9, TP10 (180–240 min). As a result, decarboxylation and further oxidation can be regarded as the major path, while hydroxylation and C–N cleavage may be considered as secondary paths. Based on the identification of TPs, as described previously, as well as on the TPs evolution kinetics, the tentative transformation pathways are summarized in Figure 4. In conclusion, VLS degradation by the g-C3N4 photocatalytic oxidation process followed three major pathways (Figure 4): (a) decarboxylation with further oxidation; (b) biphenyl or tetrazole moiety hydroxylation; and (c) rupture of the C–N bond in the tertiary amine group.

2.3. Photocatalytic Transformation Products and Pathways of Valsartan by UV-Vis/TiO2 Process

LC–HRMS data on the identification of VLS TPs by TiO2 photocatalysis are summarized in Table 2, while the respective chromatograms are depicted in Figure 5. TiO2 photocatalytic oxidation is based on OH radicals, which react preferably with the electron-rich groups of organic substances via addition/elimination pathways, H-abstraction, and electron transfer [21]. The OH additions to aromatic moieties or unsaturated bonds compete overwhelming to H-abstraction. Electron transfer with OH is limited to very electron rich systems. In the case of valsartan, such electron-rich functional groups are the phenyl and tetrazole moieties. For tetrazole, OH radicals react at the -NH position either by electron transfer or H-abstraction [25]. The oxidation of primary, secondary, and tertiary aliphatic carbons is initiated by hydrogen atom abstraction forming a carbon-centered radical. The stabilization of such carbon-centered radicals can lead to the addition of molecular oxygen to form peroxy radicals, which subsequently yield the corresponding oxidation products as mentioned previously. Moreover, for the N-methylated amide function, abstraction by OH radicals takes place mainly from the N-methyl group [26]. Finally, the reaction of carboxylic acids (i.e., 2-methylbutanoic acid group of VLS) with OH radicals results in little decarboxylation and preferably proceeds through H-abstraction [27].
The identified TPs can be rationalized based on the above principal reaction mechanisms of OH radicals towards the functionalities present in VLS molecule. More specifically, three TPs, T-TP1, T-TP3 and T-TP7, with [M + H]+ at m/z 406.2225, 364.1759 and 336.1810 are in common with the TPs detected by g-C3N4 catalyst, GCN-TP2, GCN-TP5 and GCN-TP6, respectively. T-TP5 with [M + H]+ at m/z 380.1706 differs 16 amu from T-TP3 and the suggested formula C20H22O3N5+ implied a hydroxylated derivative. T-TP2 with [M + H]+ at m/z 362.1599 is 2 amu less than T-TP3 and the suggested formula C20H20O2N5+ point out the formation of a double bond or a ring on the TP structure. T-TP2 was assigned to a cyclization product, with tetrazole –NH group participating in the cyclization after the abstraction of labile hydrogen by OH radicals.
Similarly, T-TP8 and T-TP6 were assigned to a hydroxy and keto derivative of T-TP2 presenting [M + H]+ at m/z 378.1550 and 376.1392 with chemical formulas of C20H20O3N5+ and C20H18O3N5+, respectively. Another evidence for the above tetra cyclic TPs (T-TP8, T-TP6) is the higher retention times compared to the precursor TPs due to the less polar character. Such cyclization derivatives are reported for VLS during oxidation by persulfate activation to SO4•− [17], but they have been identified also for the structurally related drug irbesartan, during photolysis [28] and hypochlorite treatment [29].
Amide bond cleavage and subsequent cyclization was considered for the formation of T-TP4 with [M + H]+ 350.1600 and C19H20O2N5+ as the suggested chemical formula. Further oxidation led to the formation of T-TP9 presenting [M + H]+ 278.1018 and C15H12ON5+. Finally, the rupture of tetrazole ring and N-substituents led to the formation of T-TP10 with a formula of C14H16N+ bearing [M + H]+ 198.1273. The above assignments can be further rationalized considering their evolution profiles (Figure 6). T-TP1, T-TP3-TP5, and T-TP7 maximized at 15 min and can be considered as primary products, while all cyclization derivatives (T-TP2, T-TP6, T-TP8 and T-TP9) peak up at longer treatment times and are considered as secondary TPs. Finally, TP10 peak up at 90 min and can be considered as late stage product. The corresponding TOC removal after 240 min of irradiation under the current experimental conditions was 15%.
Based on the structure assignments and TPs evolution profiles, the tentative transformation pathways are summarized in Figure 7. In conclusion, the VLS TiO2 photocatalytic degradation process followed four major pathways (Figure 7): (a) N-lateral chain oxidation; (b) cyclization; (c) hydroxylation; and (d) cleavage of the amide bond. Two main differences can be noted compared to the g-C3N4 process., i.e., the presence of cyclization TPs and the absence of hydroxy-derivatives of VLS.

3. Materials and Methods

3.1. Materials and Chemicals

Valsartan (98%) was purchased from Sigma—Aldrich. Methanol (MeOH) and water of LC-MS grade was supplied by Fisher Scientific (Loughborough, UK). Urea (99.5%) was obtained from Acrōs Organics (Geel, Belgium). Oasis HLB (divinylbenzene/N-vinylpyrrolidone copolymer) cartridges (60 mg, 3 mL) from Waters (Mildford, MA, USA) were used for the extraction of TPs. Two different semiconductor materials were used. The first included the aeroxide TiO2-P25 supplied by the Evonik-Degussa Corporation (BET specific surface area (SSA) 50 ± 15 m2g−1, 80% anatase, 20% rutile, average primary particle size 21 nm, Eg = 3.15 eV). The second, the g-C3N4 catalyst, was synthesized with the use of urea as a precursor compound. The urea was placed in an aluminum crucible and was dried in 90 °CC for 24 h. After that, was calcinated in air at 500 °CC with heating rate of 10 °C min−1. The furnace was cooled down naturally and the collected yellow color solid was ground well into a powder in an agate mortar. The main physicochemical properties of g-C3N4 were as follows: specific surface area 35 m2g−1, particle size of 25 nm, Eg = 2.82 eV [30].

3.2. Photocatalytic Treatment Experiments

A solar simulator (Suntest XLS+, Atlas, Linsengericht, Germany) equipped with a xenon lamp (2.2 kW) was used for performing photocatalytic experiments UV–vis irradiation (simulated solar light, λ > 290 nm) using a 290 nm cut-off glass filter. Before illumination, 0.1 mL of valsartan standard solution in methanol (C = 5000 mgL−1) was added to 100 mL bidistilled water in order to achieve an initial concentration (C0) of 5 mgL−1 and then 100 mgL−1 of photocatalyst was added under stirring (600 rpm). The suspension was loaded in Pyrex reactor (250 mL) and kept in the dark for 30 min in order to achieve the adsorption equilibrium. Adsorption experiments took place in dark conditions showed adsorption percentages of 14.3% and 1.8% for TiO2 and g-C3N4, respectively. The above experimental conditions were selected in order to obtain not so fast kinetics and to facilitate the identification and the follow-up of the transformation products. A constant radiation intensity (500 W m−2) was kept throughout the experiments, while the temperature was kept at 23 ± 1 °C by a water circuit in the double-jacked photoreactor and air circulation. Samples ≈ 2 mL were periodically withdrawn and filtered by 0.22 μm filters for further LC-MS and total organic carbon (TOC) analysis using a TOC-L CSH/CSN (Shimadzu, Kyoto, Japan) analyzer.

3.3. Identification of Transformation Products by Liquid Chromatography-High Resolution Mass Spectrometry

The analysis of the photocatalytically treated aqueous samples was performed by accurate mass high resolution liquid chromatography-mass spectrometry (LTQ-Orbitrap XL, Thermo Fisher Scientific, Inc., GmbH, Bremen, Germany). The instrument combines a UHPLC Accela LC system (Accela LC pump, Accela Autosampler) and a linear–ion–trap–Orbitrap™ hybrid mass spectrometer. ESI ionization was performed in both positive and negative mode. The analysis was performed according to the following conditions: gradient elution with 0.1% formic acid in LC-MS grade water (mobile phase A) and 0.1% formic acid in LC-MS grade methanol (mobile phase B); Speedcore-Fortis diphenyl (2.1 mm × 50 mm, 2.6 μm particle size) column operated at 35 °C; gradient elution started with 95% A (2 min) and progressed according to 90% A, 70% A and 50% A in 3, 5 and 10 min, respectively, finally returned to 80% A and initial conditions in 15 and 18 min, respectively, with 1 min column re-equilibration time; flow rate 0.25 mL/min; injection volume 20 µL. The mass range was scanned within 90−600 m/z, while mass spectra data were recorded using a resolving power of 60.000 and 15.000 in FT-MS mode for MS and MS2/MS3 scans, respectively. A mass accuracy of ±5 ppm was adopted by performing external calibration of the Orbitrap mass analyzer. The processing of data was performed by Thermo Xcalibur 2.1 software (Thermo Electron, San Jose, CA, USA).

3.4. Determination of OH Radicals by Fluorescence Measurements

The terephthalic acid (TA) (98%, Sigma-Aldrich, St. Louis, MO, USA) method was used for the quantification of the generated OH radicals. Aqueous solutions (100 mL) of TA (5 × 10−4 M) and NaOH (2 × 10−3 M, 99% Riedel de Haẽn, Seelze, Germany) were prepared and then the catalysts were added to the solutions, which were placed to the reactor. The experimental conditions remained the same with the photocatalytic experiments. Samplings (5 mL) were performed at different time intervals and samples were filtered with 0.22 μm filters. The fluorescence peak at 425 nm (excitation wavelength at 310 nm) is ascribed to 2-hyroxyterephthalic acid (TAOH). A calibration curve plotting the fluorescence intensity of standard TAOH took place for measuring the concentrations of OH.

4. Conclusions

The photocatalytic degradation pathways of the valsartan pharmaceutical were studied in the presence of g-C3N4 and TiO2 catalysts using LC-MS-Orbitrap high resolution accurate mass spectrometry. Ten transformation products were identified for each catalyst, but only three of them are in common, suggesting the different degradation pathways followed. For g-C3N4, the major paths included decarboxylation and subsequent oxidation, hydroxylation, and cleavage of C–N bond. On the other hand, in the presence of TiO2 cyclization, TPs are abundant and hydroxylation occurs in the first stage products due to the higher production of OH radicals. Thus, the generation of transformation products is greatly influenced by the catalytic mechanism suggesting that their identification is highly significant in photocatalytic processes or in other oxidoreductive processes in the environment. In the case of TiO2, all transformation products were also degraded for more than 60%, but, in the presence of g-C3N4, some products still increased their concentrations within the time framework of 240 min. Overall, this work demonstrated the importance of identifying the TPs for the assessment of photocatalytic processes since they can be more persistent and/or toxic depending on the catalyst used.

Author Contributions

Conceptualization, I.K. and F.B.; methodology, F.B.; formal analysis, I.K. and F.B.; investigation, F.B.; resources, I.K.; writing—original draft preparation, F.B. and I.K.; writing—review and editing, F.B. and I.K.; visualization, F.B.; supervision, I.K.; funding acquisition, F.B. and I.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research work was funded by the Hellenic foundation for Research and Innovation (HFRI) under the HFRI PhD fellowship grant (Fellowship number: 269, Project number: 82697).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors would like to thank the unit of environmental, organic and biochemical high resolution–Orbitrap–LC–MS analysis of the University of Ioannina for providing access to the instrumentation facilities.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Taoufik, N.; Boumya, W.; Janani, F.Z.; Elhalil, A.F.Z.; Mahjoubi, N.B. Removal of emerging pharmaceutical pollutants: A systematic mapping study review. J. Environ. Chem. Eng. 2020, 8, 104251. [Google Scholar] [CrossRef]
  2. Kosma, C.I.; Lambropoulou, D.A.; Albanis, T.A. Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466–467, 421–438. [Google Scholar] [CrossRef] [PubMed]
  3. Kosma, C.I.; Nannou, C.I.; Boti, V.I.; Albanis, T.A. Psychiatrics and selected metabolites in hospital and urban wastewaters: Occurrence, removal, mass loading, seasonal influence and risk assessment. Sci. Total Environ. 2019, 659, 1473–1483. [Google Scholar] [CrossRef]
  4. Antonopoulou, M.; Kosma, C.; Albanis, T.; Konstantinou, I. An overview of homogeneous and heterogeneous photocatalysis applications for the removal of pharmaceutical compounds from real or synthetic hospital wastewaters under lab or pilot scale. Sci. Total Environ. 2021, 765, 144163. [Google Scholar] [CrossRef]
  5. Papageorgiou, M.; Zioris, I.; Danis, T.; Bikiaris, D.; Dimitra Lambropoulou, D. Comprehensive investigation of a wide range of pharmaceuticals and personal care products in urban and hospital wastewaters in Greece. Sci. Total Environ. 2019, 694, 133565. [Google Scholar] [CrossRef] [PubMed]
  6. Nödler, K.; Hillebrand, O.; Idzik, K.; Strathmann, M.; Schiperski, F.; Zirlewagen, J.; Licha, T. Occurrence and fate of the Angiotensin II receptor antagonist transformation product Valsartan acid in the water cycle-A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame. Water Res. 2013, 47, 6650–6659. [Google Scholar] [CrossRef]
  7. Brunetto, M.R.; Contreras, Y.; Clavijo, S.; Torres, D.; Delgado, Y.; Ovalles, F.; Ayala, C.; Gallignani, M.; Estela, J.M.; Martin, V.C. Determination of losartan, telmisartan and valsartan by direct injection human urine into a column-switching liquid chromatographic system with fluorescence detection. J. Pharm. Biomed. Anal. 2009, 50, 194–199. [Google Scholar] [CrossRef]
  8. Zhou, S.; Paolo, C.D.; Wu, X.; Shao, Y.; Seiler, T.B. Optimization of screening-level risk assessment and priority selection of emerging pollutants–The case of pharmaceuticals in European surface water. Environ. Int. 2019, 128, 1–10. [Google Scholar] [CrossRef]
  9. Castro, C.; Rodriguez, I.; Ramil, M.; Cela, R. Selective determination of sartan drugs in environmental water samples by mixed-mode solid-phase extraction and liquid chromatography tandem mass spectrometry. Chemosphere 2019, 224, 562–571. [Google Scholar] [CrossRef]
  10. Pena-Guzman, C.; Ulloa-Sanchez, S.; Mora, K.; Helena-Bustos, R.; Lopes-Barrera, E.; Alvarez, J.; Rodriguez-Pinzon, M. Emerging pollutants in the urban water cycle in Latin America: A review of the current literature. J. Environ. Manag. 2019, 237, 408–423. [Google Scholar] [CrossRef]
  11. Kosma, C.I.; Lambropoulou, D.A.; Albanis, T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179, 804–817. [Google Scholar] [CrossRef] [PubMed]
  12. Kosma, C.I.; Lambropoulou, D.A.; Albanis, T.A. Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters. Water Res. 2015, 70, 436–448. [Google Scholar] [CrossRef] [PubMed]
  13. Konstantinou, I.K.; Albanis, T.A. Photocatalytic transformation of pesticides in aqueous titanium dioxide suspensions using artificial and solar light: Intermediates and degradation pathways. Appl. Catal. B Environ. 2003, 42, 319–335. [Google Scholar] [CrossRef]
  14. Kanakaraju, D.; Glass, B.D.; Oelgemöller, M. Advanced oxidation process-mediated removal of pharmaceuticals from water: A review. J. Environ. Manag. 2018, 219, 189–207. [Google Scholar] [CrossRef]
  15. Mamba, G.; Mishra, A.K. Graphitic carbon nitride (g-C3N4) nanocomposites: A new and exciting generation of visible light driven photocatalysts for environmental pollution remediation. Appl. Catal. B Environ. 2016, 198, 347–377. [Google Scholar] [CrossRef]
  16. Wang, Y.; Wang, X.; Antonietti, M. Polymeric Graphitic Carbon Nitride as a Heterogeneous Organocatalyst: From Photochemistry to Multipurpose Catalysis to Sustainable Chemistry. Angew. Chem. Int. Ed. 2012, 51, 68–89. [Google Scholar] [CrossRef]
  17. Arvaniti, O.S.; Bairamis, F.; Konstantinou, I.; Mantzavinos, D.; Frontistis, Z. Degradation of antihypertensive drug valsartan in water matrices by heat and heat/ultrasound activated persulfate: Kinetics, synergy effect and transformation products. CEJ Adv. 2020, 4, 100062. [Google Scholar] [CrossRef]
  18. Martinez-Pachon, D.; Ibanez, M.; Hernandez, F.; Torres-Palma, R.A.; Moncayo-Lasso, A. Photo-electro-Fenton process applied to the degradation of valsartan: Effect of parameters, identification degradation routes and mineralization in combination with a biological system. J. Environ. Chem. Eng. 2018, 6, 7302–7311. [Google Scholar] [CrossRef]
  19. Serna-Galvis, E.A.; Isaza-Pineda, L.; Moncayo-Lasso, A.; Ibanez, M.; Torres-Palma, R.A. Comparative degradation of two highly consumed antihypertensives in water by sonochemical process. Determination of the reaction zone, primary degradation products and theoretical calculations on the oxidative process. Ultrason. Sonochem. 2019, 58, 104635. [Google Scholar] [CrossRef]
  20. Diehle, M.; Gebhardt, W.; Pinnekamp, J.; Schäffer, A.; Linnemann, V. Ozonation of valsartan: Structural elucidation and environmental properties of transformation products. Chemosphere 2019, 216, 437–448. [Google Scholar] [CrossRef]
  21. Park, H.; Kim, H.I.; Moon, G.H.; Choi, W. Photoinduced charge transfer processes in solar photocatalysis based on modified TiO2. Energy Environ. Sci. 2016, 9, 411–433. [Google Scholar] [CrossRef] [Green Version]
  22. Bennett, J.E.; Summers, R. Product studies of the mutual termination reactions of sec-alkylperoxy radicals: Evidence for non-cyclic termination. Can. J. Chem. 1974, 52, 1377–1379. [Google Scholar] [CrossRef]
  23. Von Sonntag, C.; Schuchmann, H.P. The Elucidation of Peroxyl Radical Reactions in Aqueous Solution with the Help of Radiation-Chemical Methods. Angew. Chem. Int. Ed. Engl. 1991, 30, 1229–1253. [Google Scholar] [CrossRef]
  24. Hu, J.; Wang, J.; Nguyen, T.H.; Zheng, N. The chemistry of amine radical cations produced by visible light photoredox catalysis. Beilstein J. Org. Chem. 2013, 9, 1977–2001. [Google Scholar] [CrossRef]
  25. Dey, G.R.; Naik, D.B.; Kishore, K.; Moorthy, P.N. Pulse radiolysis study of 5-amino tetrazole in aqueous solutions. Radiat. Phys. Chem. 1996, 47, 559–562. [Google Scholar]
  26. Hayon, E.; Ibata, T.; Lichtin, N.N.; Simic, M. Sites of attack of hydroxyl radicals on amides in aqueous solution. J. Am. Chem Soc. 1970, 92, 3898–3903. [Google Scholar] [CrossRef]
  27. Madhavan, V.; Levanon, H.; Neta, P. Decarboxylation by SO4 Radicals. Radiat. Res. 1978, 76, 15–22. [Google Scholar] [CrossRef]
  28. Shah Ravi, P.; Sahu, A.; Singh, S. Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn on-line H/D exchange and LC–NMR. J. Pharm. Biomed. Anal. 2010, 51, 1037–1046. [Google Scholar] [CrossRef]
  29. Romanucci, V.; Siciliano, A.; Guida, M.; Libralato, G.; Luongo, G.; Previtera, L.; Di Fabio, G.; Zarrelli, A.; Saviano, L. Disinfection by-products and ecotoxic risk associated with hypochlorite treatment of irbesartan. Sci. Total Environ. 2020, 712, 135625. [Google Scholar] [CrossRef]
  30. Bairamis, F.; Konstantinou, I.; Petrakis, D.; Vaimakis, T. Enhanced Performance of Electrospun Nanofibrous TiO2/g-C3N4 Photocatalyst in Photocatalytic Degradation of Methylene Blue. Catalysts 2019, 9, 880. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Photocatalytic degradation kinetics of valsartan by TiO2 and g-C3N4 catalysts ((valsartan) = 5 mg L−1; (catalyst) = 100 mg L−1; I = 500 Wm−2).
Figure 1. Photocatalytic degradation kinetics of valsartan by TiO2 and g-C3N4 catalysts ((valsartan) = 5 mg L−1; (catalyst) = 100 mg L−1; I = 500 Wm−2).
Reactions 03 00012 g001
Figure 2. Fluorescence spectra intensity of hydroxy-terephthalic acid (OHTA) formation by TiO2 and g-C3N4, ((catalyst) = 100 mg L−1; I = 500 Wm−2).
Figure 2. Fluorescence spectra intensity of hydroxy-terephthalic acid (OHTA) formation by TiO2 and g-C3N4, ((catalyst) = 100 mg L−1; I = 500 Wm−2).
Reactions 03 00012 g002
Figure 3. Evolution profiles of major (a) and minor (b) VLS TPs by g-C3N4 photocatalytic oxidation process.
Figure 3. Evolution profiles of major (a) and minor (b) VLS TPs by g-C3N4 photocatalytic oxidation process.
Reactions 03 00012 g003
Figure 4. Proposed degradation pathways of valsartan by the g-C3N4 photocatalytic oxidation.
Figure 4. Proposed degradation pathways of valsartan by the g-C3N4 photocatalytic oxidation.
Reactions 03 00012 g004
Figure 5. (al). LC-HR-MS TPs accurate-mass extracted chromatograms of TiO2-photocatalytically treated (reaction time 15 min) VLS aqueous solutions.
Figure 5. (al). LC-HR-MS TPs accurate-mass extracted chromatograms of TiO2-photocatalytically treated (reaction time 15 min) VLS aqueous solutions.
Reactions 03 00012 g005
Figure 6. Evolution profiles of major (a) and minor (b) VLS TPs by TiO2 photocatalytic oxidation process.
Figure 6. Evolution profiles of major (a) and minor (b) VLS TPs by TiO2 photocatalytic oxidation process.
Reactions 03 00012 g006
Figure 7. The proposed degradation pathways of valsartan by TiO2 photocatalytic oxidation.
Figure 7. The proposed degradation pathways of valsartan by TiO2 photocatalytic oxidation.
Reactions 03 00012 g007
Table 1. UPLC-ESI-HR-MS data (pseudo-molecular ions (M + H)+ or (M − H) */(M + Na)+; chemical formula; mass error Δ(ppm); and ring-double\bond equivalents, RDB) for VLS and transformation products by g-C3N4 photocatalytic oxidation.
Table 1. UPLC-ESI-HR-MS data (pseudo-molecular ions (M + H)+ or (M − H) */(M + Na)+; chemical formula; mass error Δ(ppm); and ring-double\bond equivalents, RDB) for VLS and transformation products by g-C3N4 photocatalytic oxidation.
VLS/TPs(M + H)+/(M + Na)+
(M − H)*
FormulaΔ(ppm)RDB
VLS436.2336
458.2145
C24H30O3N5
C24H29O3N5Na
−1.61912.5
GCN-TP1392.2437
414.2253
C23H30ON5
C23H29ON5Na
−2.08311.5
GCN-TP2406.2227
428.2045
C23H28O2N5
C23H27O2N5Na
−2.71212.5
GCN-TP3450.2148 *C24H28O4N52.66413.5
GCN-TP4450.2144 *C24H28O4N5−0.50613.5
GCN-TP5364.1759
386.1574
C20H22O2N5
C20H21O2N5Na
−2.47512.5
GCN-TP6336.1810
358.1628
C19H22ON5
C19H21ON5Na
−2.72711.5
GCN-TP7356.1341
378.1161
C17H18O4N5
C17H17O4N5Na
−3.48311.5
GCN-TP8267.0868
289.0685
C14H11O2N4
C14H10O2N4Na
−3.22811.5
GCN-TP9400.1238
422.1057
C18H18O6N5
C18H17O6N5Na
−3.52312.5
GCN-TP10202.1433
224.1249
C10H20O3N
C10H19O3NNa
−2.5231.5
Table 2. UPLC-ESI(+)-HR-MS data (pseudo-molecular ions (M + H)+/(M + Na)+; chemical formula; mass error Δ(ppm); and ring-double bond equivalents, RDB) for VLS transformation products by TiO2 photocatalytic oxidation.
Table 2. UPLC-ESI(+)-HR-MS data (pseudo-molecular ions (M + H)+/(M + Na)+; chemical formula; mass error Δ(ppm); and ring-double bond equivalents, RDB) for VLS transformation products by TiO2 photocatalytic oxidation.
TPs(M + H)+/(M + Na)+FormulaΔ(ppm)RDB
T-TP1406.2225
428.2044
C23H28O2N5
C23H27O2N5Na
−3.08112.5
T-TP2362.1599
384.1419
C20H20O2N5
C20H19O2N5Na
−3.34513.5
T-TP3364.1759
386.1575
C20H22O2N5
C20H21O2N5Na
−2.47512.5
T-TP4350.1600
372.1418
C19H20O2N5
C19H19O2N5Na
−3.37412.5
T-TP5380.1706
402.1523
C20H22O3N5
C20H21O3N5Na
−2.96212.5
T-TP6376.1392
398.1211
C20H18O3N5
C20H17O3N5Na
−3.18014.5
T-TP7336.1810
358.1629
C19H22ON5
C19H21ON5Na
−2.72711.5
T-TP8378.1550
400.1368
C20H20O3N5
C20H19O3N5
−2.81913.5
T-TP9278.1028
300.0847
C15H12ON5
C15H11ON5
−2.86412.5
T-TP10198.1273C14H16N−1.8487.5
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bairamis, F.; Konstantinou, I. Photocatalytic Degradation Pathways of the Valsartan Drug by TiO2 and g-C3N4 Catalysts. Reactions 2022, 3, 160-171. https://doi.org/10.3390/reactions3010012

AMA Style

Bairamis F, Konstantinou I. Photocatalytic Degradation Pathways of the Valsartan Drug by TiO2 and g-C3N4 Catalysts. Reactions. 2022; 3(1):160-171. https://doi.org/10.3390/reactions3010012

Chicago/Turabian Style

Bairamis, Feidias, and Ioannis Konstantinou. 2022. "Photocatalytic Degradation Pathways of the Valsartan Drug by TiO2 and g-C3N4 Catalysts" Reactions 3, no. 1: 160-171. https://doi.org/10.3390/reactions3010012

APA Style

Bairamis, F., & Konstantinou, I. (2022). Photocatalytic Degradation Pathways of the Valsartan Drug by TiO2 and g-C3N4 Catalysts. Reactions, 3(1), 160-171. https://doi.org/10.3390/reactions3010012

Article Metrics

Back to TopTop